PD-1 & PD-L1 Inhibitors Market Analysis, Forecast to 2025by PSMR Industry Web Marketing
The global programmed death-1 (PD-1) and programmed death ligand-1
(PD-L1) inhibitors market is valued at an estimated $4,926.4 million in 2016,
and it is expected to grow at a CAGR of 23.4% during 2017 - 2025. The growth of
the global market is largely driven by the increased investment and funding,
strong pipeline, and improved safety and efficacy.
Explore Report with Detailed TOC at: https://www.psmarketresearch.com/market-analysis/pd1-and-pdl1-inhibitors-market
Some of the other factors driving the growth of the global market
include technological advancements and innovations, and high prevalence of
cancer. Less number of competitors and expected launch of Phase III drug
candidates will create ample growth opportunities for the global market.
However, high cost of research and therapy, and stringent and time consuming
regulatory process are the key barriers for the growth of the global market.
Explore Report Sample
Created on Sep 1st 2017 14:56. Viewed 605 times.